IN BRIEF: Indivior names former Collegium Pharmaceutical chief as CEO

Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use - Appoints ...

Alliance News 27 February, 2025 | 2:46PM
Email Form Facebook Twitter LinkedIn RSS

Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use - Appoints Non-Executive Director Joe Ciaffoni as chief executive officer, replacing Mark Crossley. The handover is expected to be after Indivior's annual general meeting in May. Indivior says Crossley is stepping down "by mutual agreement" and "following a distinguished tenure" as CEO since 2020. Crossley joined the board in December. Most recently, he was CEO of Nasdaq-listed Collegium Pharmaceutical Inc.

Current stock price: 669.00 pence, up 2.8% in London on Thursday

12-month change: down 61%

By Tom Waite, Alliance News editor

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Indivior PLC Ordinary Share 678.00 GBX 4.15 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures